Published: 2020-11-12 14:39 | Updated: 2020-11-12 14:40

28,3 MSEK from Cancerfonden to researchers at ANA Futura

Congratulations to the 10 researchers in ANA Futura who received funds from Cancerfonden 2021-2023.

CIM

Research projects

Niklas Björkström, Researcher
Title: "Dissecting immune cell - tumor cell interactions in the cholangiocarcinoma microenvironment"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 4 500 000 SEK

 

Benedict Chambers, Researcher
Title: "Innate lymphocytes in cancer: the role of activation and inhibition"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 2 400 000 SEK

 

Hans Gustaf Ljunggren, Professor
Title: "Continued development and implementation of novel NK cell-based immunotherapies for treatment of human hematological malignancies"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 750 000 SEK

 

Jakob Michaelsson, Researcher
Title: "Diversity and Functional Regulation of Tumor-infiltrating Natural Killer Cells in the Human Lung"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 000 000 SEK

 

Johan Sandberg, Professor
Title: "The potential of innate-like MAIT cells in cancer: Immunobiology, immunotherapy and immunopathology"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 000 000 SEK

Labmed

Research projects

Mikael Björnstedt, Professor
Title: "Redoxaktiva selenföreningar i behandlingen av cancer - translationella och kliniska studier"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 000 000 SEK

 

Helen Kaipe, Researcher
Title: "Exploring tumor-infiltrating T cells and cancer-associated fibroblasts in the pancreatic tumor microenvironment - the role of chemokines for T cell infiltration"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 2 400 000 SEK

 

Anna Pasetto, Assistant professor
Title: "Establishing a platform for the treatment of Hepatocellular Carcinoma using genetically modified T cells"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 2 400 000 SEK

 

Matti Sällberg, Professor
Title: "Genetic vaccines and immune-based therapies to prevent cancer caused by chronic hepatitis B, C and D virus infections: Therapy development and models"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 750 000 SEK

 

Planning group

Jonas Fuxe, Professor
Title: "Swe-EMT; Svenska nätverket för translationella studier av cell plasticitet och cancer metastasering"
Funding granted: 2021-01-01 - 2022-12-31, total amount: 150 000 SEK